Here is what the page “FTC Seeks Contempt Ruling Against Martin Shkreli for Violating Pharma Industry Ban” contains. Federal Trade Commission has asked a federal court to hold Martin Shkreli in contempt, alleging he 'flagrantly' violated a court order that banned him from working in the pharmaceutical industry. The order stems from a previous antitrust case in which Shkreli, often dubbed 'Pharma Bro,' was found to have orchestrated anticompetitive practices. The FTC contends that Shkreli has continued to engage in activities that flout the ban, though specific details of the alleged violations were not immediately disclosed.
This move signals the agency's intent to enforce its orders strictly and could lead to additional penalties for Shkreli, who has already faced criminal convictions and civil judgments. The case underscores ongoing regulatory scrutiny of pharmaceutical executives and the consequences of defying federal mandates. This listing links straight to the original page, where the content is available in full.